Monthly Archives: May 2013
Botox is one of the names for the neurotoxic protein called botulinum toxin, which in large doses causes botulism, a rare but serious illness caused by bacteria. Botox currently has many uses, but is most commonly known for its cosmetic … Read More
‘Magic Bullet’ Development Could Treat Acute Lung Injury
A study conducted through Queen’s University has developed a drug described as a ‘magic bullet’ to be used in the treatment of lung injury. The drug’s success could potentially become the first treatment of its kind to be used in … Read More
Class I Recall Issued for GE Healthcare Incubators
GE Healthcare designed two products – the Giraffe OmniBed and the Giraffe Incubator – to provide thermal and developmental care to newborn babies. These products are used to maintain the body temperature and, in some models, the oxygen level of newborn babies. The Giraffe … Read More
New Drug-Induced Liver Injury Study Released
A recent case and literature review reveals that drug-induced liver injury, typically in the form of acute hepatocellular injury with autoimmune features, could potentially be class effect of tumor necrosis factor-alpha antagonists. Researchers worked among six different cases of drug-induced … Read More
A new asthma drug being developed by Sanofi and Regeneron Pharmaceuticals, Dupilumab, appears to help those asthma patients whose condition does not respond well to existing medicines. The results of a small clinical trial – 12 weeks – was published … Read More
California to cut off funding for database that monitors prescription drug usage
By the end of this year, the state’s prescription drug monitoring program may run out of money. California is about to stop funding for a database that monitors prescription drug use and abuse, unless people like Robert Pack can convince … Read More